Bioreactor Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

An increasing population of elderly people who are prone to chronic diseases such as cardiovascular disease, diabetes, and many more is expected to drive demand for the bioreactor market. According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally. An estimated 17.9 million people died from CVDs in 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. Owing to the glaring statistics, and rising prevalence of cardiovascular diseases (CVDs), it becomes imperative to opt for advanced bioreactors for better efficiency and accurate result. According to UnivDatos Market Insights (UMI)’ research report “global bioreactor market”, the market is expected to witness a CAGR of around 7% growth during the forecast period 2021-2027F. Furthermore, a rise in research and development, and an increase in funding from private and government are also expected to contribute to market growth.

Based on usage, the market is classified into lab-scale production, pilot-scale production, and full-scale production. Amongst usage, the pilot-scale production category accounted for a significant share in the market due to development in the pharmaceutical and biotechnology industry and an increase in the number of clinical and pre-clinical trial studies.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22012   

Based on end-user, the market is classified into R&D departments and institutes, CROs (contract research organizations), biopharmaceuticals companies and manufacturing, and CMOS (contract manufacturing organizations). Amongst end-users, the R&D department and institutes category accounted for a significant share in the market due to the development of novel & innovative systems, and the increasing adoption of advanced technologies to ease complex manufacturing. 

North America to witness extensive growth

For a better understanding of the market adoption of the bioreactor market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the bioreactor industry in 2020 owing to the presence of well-established market players and the rising geriatric population in the region.

For more informative information, please visit us – https://univdatos.com/report/bioreactors-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global bioreactor market are BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Eppendorf AG, Getinge, Infors HT, Merck KGAA, Sartorius AG, Solaris Biotech Solutions, Thermo Fisher Scientific, Inc. Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions. 

“Global Bioreactor Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.      

Market Segmentations:

1.     By Material Type (Glass, Stainless Steel, Single Use)

2.     By Control Type (Manual, Automated)

3.     By Usage (Lab-Scale Production, Pilot Scale Production, Full-Scale Production)

4.     By End-Users (Pharmaceuticals, Academic and Research, and Hospitals)

5.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

6.     By Company (R&D Departments & Institutes, CROs (Contract Research Organizations), Biopharmaceuticals Companies & Manufacturers, CMOs (Contract Manufacturing Organizations)). 

Key questions answered in the study:

1.     What are the current and future trends of the global bioreactor industry?

2.     How the industry has been evolving in terms of material type, control type, usage and end-users?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the global bioreactor industry?

5.     What is the customer orientation, purchase behavior, and expectations from the global bioreactor suppliers across various region and countries? 

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL BIOREACTOR MARKET COVID-19 IMPACT

6 GLOBAL BIOREACTOR MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY MATERIAL TYPE

8 MARKET INSIGHTS BY CONTROL TYPE

9 MARKET INSIGHTS BY USAGE

10 MARKET INSIGHTS BY END-USERS

11 MARKET INSIGHTS BY REGION

12 BIOREACTOR MARKET DYNAMICS

13 BIOREACTOR MARKET OPPORTUNITIES

14 BIOREACTOR MARKET TRENDS

15 LEGAL & REGULATORY FRAMEWORK

16 DEMAND AND SUPPLY SIDE ANALYSIS

17 VALUE CHAIN ANALYSIS

18 COMPETITIVE SCENARIO

19 COMPANY PROFILED

20 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%| 

·       Preventive Healthcare Technologies and Services Market to Reach US$ 493.1 Billion by 2027 Globally |CAGR: 10.5%| 

·       Internet of Medical Things Market to Reach US$ 284.5 Billion by 2027 Globally | CAGR: 18.5% |

·       Healthcare Analytics Market to Reach US$ 118.2 Billion by 2027 Globally |CAGR: 31%|